How to build an integrated medtech development roadmap
A useful roadmap connects product definition, evidence, regulation, manufacturing, funding and adoption around explicit decision gates.
Read the insightMedtech insights
Clear thinking for consequential decisions.
Practical, evidence-led perspectives on the product, evidence, investment and adoption questions that determine whether medical technology creates real-world value.
Latest thinking
Start with the question that matters.
What evidence does a medtech company need for NHS adoption?
Regulatory evidence is essential, but adoption also depends on workflow, economic, implementation and pathway evidence.
Read the insightTen questions that strengthen medtech due diligence
Test the relationship between the technology, claims, evidence, regulatory route, delivery plan and commercial value.
Read the insightGenvissa perspective
The critical path is cross-functional.
The most important medtech questions do not belong to one department.
Product choices change evidence needs. Evidence changes regulatory and market-access options. Manufacturing decisions change cost, quality and scale. Funding only creates value when it buys down the right risks in the right order.
Our insights focus on those dependencies and on the decisions that founders, boards and investors must be able to defend.
Apply the thinking
Working through a decision that cannot remain unclear?
Tell us the context, consequence and next milestone. We will quickly establish whether Genvissa can help.